{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:27:27Z","timestamp":1760315247738,"version":"build-2065373602"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,12]]},"DOI":"10.7759\/cureus.94383","type":"journal-article","created":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:26:17Z","timestamp":1760264777000},"source":"Crossref","is-referenced-by-count":0,"title":["Postoperative Pelvic Abscess Risk in Gynecologic Surgery: A Four-Year Single Institution Experience"],"prefix":"10.7759","author":[{"given":"Dwight","family":"Im","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000000106","article-title":"Use of topical hemostatic agents in gynecologic surgery","volume":"69","author":"Wysham WZ","year":"2014","unstructured":"Wysham WZ, Roque DR, Soper JT. Use of topical hemostatic agents in gynecologic surgery. Obstet Gynecol Surv. 2014, 69:557-63. 10.1097\/OGX.0000000000000106","journal-title":"Obstet Gynecol Surv"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.1916751","article-title":"Impact of an active hemostatic product treatment approach on bleeding-related complications and hospital costs among inpatient surgeries in the United States","volume":"24","author":"Iannitti DA","year":"2021","unstructured":"Iannitti DA, Kim C, Ito D, Epstein J. Impact of an active hemostatic product treatment approach on bleeding-related complications and hospital costs among inpatient surgeries in the United States. J Med Econ. 2021, 24:514-23. 10.1080\/13696998.2021.1916751","journal-title":"J Med Econ"},{"key":"ref3","unstructured":"Surgicel Absorbable Hemostat Instructions for Use. Johnson & Johnson, Inc. (2022). Accessed. September 16, 2025: https:\/\/www.jnjmedtech.com\/en-US\/product\/surgicel-powder-absorbable-hemostat."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2021.09.004","article-title":"Topical coagulant agents","volume":"102","author":"Sheppard OO","year":"2022","unstructured":"Sheppard OO, Foje NA. Topical coagulant agents. Surg Clin North Am. 2022, 102:65-83. 10.1016\/j.suc.2021.09.004","journal-title":"Surg Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znad361","article-title":"Topical haemostatic agents in surgery","volume":"111","author":"Brown KG","year":"2024","unstructured":"Brown KG, Solomon MJ. Topical haemostatic agents in surgery. Br J Surg. 2024, 111:1. 10.1093\/bjs\/znad361","journal-title":"Br J Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2023.2242776","article-title":"A contemporary systematic review of the complications associated with SURGICEL","volume":"20","author":"Masoudi M","year":"2023","unstructured":"Masoudi M, Wiseman J, Wiseman SM. A contemporary systematic review of the complications associated with SURGICEL. Expert Rev Med Devices. 2023, 20:741-52. 10.1080\/17434440.2023.2242776","journal-title":"Expert Rev Med Devices"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10047-005-0296-x","article-title":"Clinical benefits and risk analysis of topical hemostats: a review","volume":"8","author":"Tomizawa Y","year":"2005","unstructured":"Tomizawa Y. Clinical benefits and risk analysis of topical hemostats: a review. J Artif Organs. 2005, 8:137-42. 10.1007\/s10047-005-0296-x","journal-title":"J Artif Organs"},{"key":"ref8","unstructured":"Tisseel [Fibrin Sealant] full Prescribing Information. Baxter International Inc. (1998). Accessed. September 16, 2025: https:\/\/baxterpi.com\/pi-pdf\/Tisseel_PI.pdf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1059-3","article-title":"Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience","volume":"17","author":"Fagotti A","year":"2010","unstructured":"Fagotti A, Costantini B, Fanfani F, Vizzielli G, Rossitto C, Lecca A, Scambia G. Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience. Ann Surg Oncol. 2010, 17:2452-8. 10.1245\/s10434-010-1059-3","journal-title":"Ann Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4293\/108680813X13693422518597","article-title":"Oxidized regenerated cellulose resembling vaginal cuff abscess","volume":"18","author":"Tam T","year":"2014","unstructured":"Tam T, Harkins G, Dykes T, Gockley A, Davies M. Oxidized regenerated cellulose resembling vaginal cuff abscess. JSLS. 2014, 18:353-6. 10.4293\/108680813X13693422518597","journal-title":"JSLS"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2015.08.002","article-title":"Intraovarian oxidized cellulose (Surgicel) mimicking acute ovarian pathology after recent pelvic surgery","volume":"10","author":"Zhang F","year":"2015","unstructured":"Zhang F, Bonidie MJ, Ventrelli SM, Furlan A. Intraovarian oxidized cellulose (Surgicel) mimicking acute ovarian pathology after recent pelvic surgery. Radiol Case Rep. 2015, 10:39-41. 10.1016\/j.radcr.2015.08.002","journal-title":"Radiol Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0b013e318276ce3f","article-title":"Oxidized regenerated cellulose imitating pelvic abscess","volume":"121","author":"Behbehani S","year":"2013","unstructured":"Behbehani S, Tulandi T. Oxidized regenerated cellulose imitating pelvic abscess. Obstet Gynecol. 2013, 121:447-9. 10.1097\/aog.0b013e318276ce3f","journal-title":"Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2022.101085","article-title":"Evaluating the risk of post-operative abscess formation following use of hemostatic agents at time of hysterectomy","volume":"44","author":"Howard M","year":"2022","unstructured":"Howard M, Staples JN, Nelamangala S, Kling C, Duska LR. Evaluating the risk of post-operative abscess formation following use of hemostatic agents at time of hysterectomy. Gynecol Oncol Rep. 2022, 44:101085. 10.1016\/j.gore.2022.101085","journal-title":"Gynecol Oncol Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/421345-postoperative-pelvic-abscess-risk-in-gynecologic-surgery-a-four-year-single-institution-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:26:18Z","timestamp":1760264778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/421345-postoperative-pelvic-abscess-risk-in-gynecologic-surgery-a-four-year-single-institution-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,12]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.94383","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,12]]}}}